Angiosarcoma is one of the most aggressive cancers and has a dismal prognosis with a 5 year overall survival rate of 30%. We are in a race against time to find a cure, not only for ourselves, but for all victims of this insidious disease. Because this is such a rare cancer, accounting for only 0.1% of adult malignancies, it is poorly understood. We recognize the fact that unless we create a patient driven initiative to fund angiosarcoma specific research, our rare cancer will never be the focus of large scale scientific endeavors that might shed light on the disease progression. We will identify laboratories that are currently conducting research on angiosarcoma and raise funds to support and augment their work. Our hope is to fund research that will reveal the molecular underpinnings of the disease which might help tailor individual therapies.
Medical Leaders Are Saying…
“Angiosarcoma Awareness has brought much needed attention to this rare disease. As a result of this groups efforts, there is now a large scale scientific endeavor aimed specifically at understanding what drives angiosarcoma. This is already being translated into new clinical trials for patients with this disease”
“Angiosarcoma awareness has been supporting our research efforts for the last two years, allowing us to make significant strides toward better understanding of the pathogenesis of angiosarcoma (AS).”
For more information on our research please,
Visit our Angiosarcoma Research Page